Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel in patients with acute myocardial infarction and COVID-19 undergoing PCI
IRCT20220813055675N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in myocardial infarction (MI) and coronavirus disease 2019 (COVID-19) comparing Ticagrelor arm with Clopidogrel arm (2 arms). Primary endpoint: Cardiovascular mortality. Started Aug 2022; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
myocardial infarction (MI)coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220813055675N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220813055675N1.